BioSpace News Archive

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it will host a virtual KOL event on Tuesday, December 8, 2020, at 8:00 am ET.

V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arter

Camber Spine , a leading innovator in spine and medical technologies has been presented with Orthopedics This Week’s “2020 Best Spine Technology Award” for its Lateral ALIF / OLIF Retractor System, an integral part of the OLIF (oblique lateral interbody fusion) technique for anterior column reconstruction

EmpiRx Health, the industry’s only value-based pharmacy benefit manager (PBM), is pleased to announce Alisia Gill has joined as the company’s new chief people officer.

American Bio Medica Corporation announced their common shares were approved for listing on OTC Markets Group Inc.'s OTCQB® Venture Market.

Zur has served as Interim Division Chief since March 2020 and also directs CHOP’s Pediatric Voice Program

Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the grant of an inducement award to the newly appointed Senior Vice President and Chief Medical Officer, Arvin Yang, M.D.,

EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a funding agreement with an investment bank to sponsor the raise of $25-$50 million for research and development via a Security Token Offering

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has prevailed in final appeal proceedings brought against its licensed European patent EP Patent 1848414, which covers the use of irreversible EGFR inhibitors in treating gefitinib and/or erlotinib resistant cancer and cancer with a T790M EGFR mutation.

Muno-Vax Biotechnologies, together with manufacturer Natstim, Ltd of Sofia, Bulgaria, has developed products that promote immune health - including supporting respiratory health, men’s prostate health, and oral health.